In this webinar hosted from EMMA International’s Solutions Delivery Specialist, Nikita Angane, she will go over the different FDA Centers, as well as the pathways to market, what a RTA (Refuse to Accept) is, and also reviewing labeling, registration, and device listings.
Nitrosamine impurities continue to be a major focus for regulators—and in 2026, scrutiny is not slowing down.
